A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis.
Luo L, Luo J, Jiang Y.
BMC Pulm Med. 2022 Jun 2;22(1):214. doi: 10.1186/s12890-022-02006-x.
PMID:35650568
Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.
Wang LL, Lu HW, Li LL, Gao YH, Xu YH, Li HX, Xi YZ, Jiang FS, Ling XF, Wei W, Li FJ, Mao B, Jiang S, Xu JF.
Respir Res. 2023 Mar 18;24(1):84. doi: 10.1186/s12931-023-02391-9.
PMID:36934266
Hemoptysis: Evaluation and Management.
O'Gurek D, Choi HYJ.
Am Fam Physician. 2022 Feb 1;105(2):144-151.
PMID:35166503
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge.
Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD.
Respiration. 2021;100(8):751-763. doi: 10.1159/000512531. Epub 2021 Jan 5.
PMID:33401266
Hemoptysis and High-Density Shadow of Both Lungs Combined with Elevated Serum G-Lipopolysaccharide Misdiagnosed as Bronchiectasis with Gram-Negative Bacterium Infection Ultimately Confirmed as Mycobacterium Iranicum Infection by CT-guided Percutaneous Lung Biopsy and Next Generation Sequencing (NGS): a Case Report and Literature Review.
Zhang Q, Shao DF, Wang MH, Li WQ, Wang HY, Rana MA, Chen Y, Liu CH, Zhang S, Jin YX, Zhang C, Zhu XY, Fu AS, Ge YL.
Prevalence of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization.
Nishihara T, Ishikawa H, Omachi N, Yamaguchi Y, Kitaguchi K, Hattori T.
Eur Radiol. 2023 Jun;33(6):4198-4204. doi: 10.1007/s00330-022-09310-4. Epub 2022 Dec 6.